You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2010 or most recent year available
Part (ii) All outpatient clients by primary drug and frequency of use (%)
| Primary drug | Not used in the past month/occasional | Once a week or less | 2–6 times per week | Daily | Frequency known (n) | Frequency unknown | |
|---|---|---|---|---|---|---|---|
| Opioids | 18.9 | 5.7 | 10.6 | 64.7 | 76318 | 12829 | |
| Cocaine | 27.2 | 18.6 | 29.8 | 24.4 | 35173 | 8534 | |
| Stimulants | 30.4 | 16.3 | 24.5 | 28.9 | 5899 | 1273 | |
| Cannabis | 21.9 | 10.9 | 16.5 | 50.7 | 47521 | 8416 |
Notes:
Percentages are of clients whose frequency of use is known (n)
Only countries reporting data related to primary drug have been included.
The following countries have been included; BE, BG, CZ, DK, EE, IE, GR, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, HR
See also Table TDI-111 for distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — TDI table — outpatient treatment centres.